Assetmark, Inc Edwards Lifesciences Corp Transaction History

Assetmark, Inc

$36.2 Billion
Q1 2025

A detailed history of Assetmark, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Assetmark, Inc holds 615 shares of EW stock, worth $46,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares

615

Previous 1,082 43.16%

Holding current value

$46,617

Previous $80,000 45.0%

% of portfolio

0.0%

Previous 0.0%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$67.95 - $76.19 $31,732 - $35,580	-467 Reduced 43.16%	615 $44,000
Q4 2024 Feb 06, 2025	BUY	$64.54 - $75.92 $61,958 - $72,883	960 Added 786.89%	1,082 $80,000
Q3 2024 Nov 01, 2024	SELL	$59.7 - $93.78 $1.39 Million - $2.18 Million	-23,286 Reduced 99.48%	122 $8,000
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $179,811 - $201,163	2,133 Added 10.03%	23,408 $2.16 Million
Q1 2024 May 06, 2024	SELL	$72.54 - $95.56 $867,215 - $1.14 Million	-11,955 Reduced 35.98%	21,275 $2.03 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $2.5 Million - $3.15 Million	-40,549 Reduced 54.96%	33,230 $2.53 Million
Q3 2023 Oct 27, 2023	BUY	$69.28 - $93.38 $717,810 - $967,510	10,361 Added 16.34%	73,779 $5.11 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $427,483 - $495,326	5,251 Added 9.03%	63,418 $5.98 Million
Q1 2023 May 05, 2023	SELL	$74.26 - $84.51 $738,812 - $840,789	-9,949 Reduced 14.61%	58,167 $4.81 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $690,513 - $884,018	10,110 Added 17.43%	68,116 $5.08 Million
Q3 2022 Nov 01, 2022	BUY	$82.37 - $107.29 $293,896 - $382,810	3,568 Added 6.55%	58,006 $4.79 Million
Q2 2022 Aug 03, 2022	BUY	$86.5 - $128.27 $859,637 - $1.27 Million	9,938 Added 22.33%	54,438 $5.18 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $2.07 Million - $2.6 Million	20,254 Added 83.54%	44,500 $5.24 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $2.4 Million - $2.95 Million	22,548 Added 1327.92%	24,246 $3.14 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $123,800 - $147,668	1,203 Added 243.03%	1,698 $192,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $11,318 - $14,142	135 Added 37.5%	495 $51,000
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $6,609 - $7,616	-84 Reduced 18.92%	360 $30,000
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $4,301 - $5,473	-60 Reduced 11.9%	444 $41,000
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $176,978 - $230,316	-2,634 Reduced 83.94%	504 $40,000
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $173,655 - $232,235	3,018 Added 2515.0%	3,138 $217,000
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $157 - $243	-3 Reduced 2.44%	120 $23,000
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $3,728 - $4,268	-52 Reduced 29.71%	123 $29,000
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $615 - $754	-10 Reduced 5.41%	175 $38,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $390 - $450	-7 Reduced 3.65%	185 $34,000
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $5,076 - $6,789	-106 Reduced 35.57%	192 $37,000
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $324 - $398	7 Added 2.41%	298 $46,000
Q1 2018 May 16, 2018	SELL	$37.19 - $47.45 $11,119 - $14,187	-299 Reduced 50.68%	291 $41,000
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $1,757 - $2,048	-52 Reduced 8.1%	590 $67,000
Q3 2017 Nov 08, 2017	BUY	$36.29 - $38.83 $3,556 - $3,805	98 Added 18.01%	642 $70,000
Q2 2017 Aug 15, 2017	SELL	N/A	-14 Reduced 2.51%	544 $64,000
Q1 2017 Sep 15, 2017	BUY	N/A	337 Added 152.49%	558 $52,000
Q4 2016 Sep 15, 2017	BUY	N/A	23 Added 11.62%	221 $21,000
Q3 2016 Sep 15, 2017	BUY	N/A	14 Added 7.61%	198 $24,000
Q1 2016 Sep 15, 2017	BUY	N/A	56 Added 43.75%	184 $16,000
Q4 2015 Sep 15, 2017	BUY	N/A	128	128 $10,000

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

486M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account